OTCPicks.com

FEATURED COMPANY

SOMATIC SYSTEMS INCORPORATED (OTC: SMAS)

Detailed Quote: http://www.otcpicks.com/quotes/SMAS.php

Company Profile:
http://www.otcpicks.com/somatic-systems/somatic-systems.htm

Somatic Systems is the worldwide center for Clinical Somatics™, the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques — conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day — to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics™ also provides performance gains and injury prevention for casual and professional athletes. Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources and opportunities at www.somatics.org.

SMAS News:

December 2 - Somatic Systems, Inc. Announces Shareholder Conference Date

Somatic Systems, Inc. (OTC: SMAS) will hold its online shareholder conference today, at 4:15 PM Eastern Time. The conference will enable shareholders to communicate directly to the CEO of the company, to get updates and learn more about the company's growth, plans, and activities.

Shareholders can enter the conference at 4:15 PM today via the Somatic Systems' website at http://somatics.org/investors/conference.

The conference occurs on the same day that the national television show "Health Forum" feature on Somatic Systems begins airing. The half-hour television show airs today at 6:30 AM on WRNN-TV in New York, and features Somatic Systems' CEO, faculty, staff, clients and professional students discussing and demonstrating how Somatic Systems' proprietary pain relief methods can help viewers achieve lasting relief from chronic pain, injury, and musculoskeletal disorders without surgery or dependence on medication. The syndicated television program will be rebroadcast four additional times on that network and on as many as 25 other stations throughout the coming year, including national airings on Women's Entertainment (WE tv) and the Travel Channel.

Somatic Systems expects to field calls about this television show and their many other exciting current activities, including their efforts with the US military, auditing and uplisting to the OTCBB, upcoming product developments and nationwide expansion, and additional media appearances on the company's horizon.

Due to the high demand for the conference, the company took questions in advance of the conference, so that as many attendees as possible can get answers to their questions. However, depending on final turnout and the course of conversation, the company expects to be able to take live questions from participants as well.

Shareholders who wish to ask questions are encouraged to visit http://somatics.org/investors/conference today as soon as possible to fill out the "Ask A Question" form if they have not done so already. If new questions arise as time passes before the conference and new company developments occur, Somatic Systems encourages shareholders to submit additional questions.

To make sure there is room for all to attend, even shareholders who just wish to observe the conference should up sign up as soon as possible for the conference at http://somatics.org/investors/conference/signup2008.

"We look forward to an open and meaningful conversation with our shareholders today," stated Somatic Systems CEO Steven Aronstein. "Somatic Systems is undergoing very exciting growth and opportunities, and we want shareholders to be able to learn as much about all of this as possible. We work hard to be available and transparent to shareholders, and we want to take this opportunity for shareholders to get their questions answered and understand the exciting directions we are headed and the shareholder value we are building."

FEATURED COMPANY

TAPSLIDE INCORPORATED (OTCBB: TSLI)

Detailed Quote: http://www.otcpicks.com/quotes/TSLI.php

Company Profile: http://www.otcpicks.com/tapslide.htm

TapSlide is set to become the world's leading publisher of iPhone, Android, and Symbian mobile applications. The company combines the industry's best mobile application developers with in-depth technical knowledge of touch-screen application development and a highly creative team of designers specializing in the creation of applications for the advertising and promotions industries. TapSlide specializes in private labeled mobile applications and application publishing services for the new breed of touch screen mobile phones. TapSlide's senior management team has created numerous past successes providing white-label technology solutions to Fortune 500 companies. The list of past successes reads like a who's-who of the technology, automotive, and publishing industries and includes (but not limited to): HP, Dell, T-Mobile, Sprint, Verizon, iRobot, Nokia, Samsung, Archos, Volvo, Mini Cooper, Thule, Nalgene, Maxim Magazine, Blender Magazine, Tiger Beat & Bop Magazines, SoBe Beverages, Americas Top Model TV Show, Best Buy, RadioShack and Blockbuster. Visit www.TapSlide.com for more information about TapSlide.

TSLI News:

November 17 - TapSlide and Global Wireless Entertainment Announce Strategic Partnership To Develop iPhone and Google Android Mobile Applications

Partnership to Deliver TapSlide Created Mobile Games and Applications for the Apple iPhone and Google Android Platforms, Based on GWE's Broad Portfolio of Licenses and Brands

TapSlide (OTCBB: TSLI) and Global Wireless Entertainment (GWE) announced a strategic partnership to explore the development of mobile games and applications for the new generation of touch screen phones based on the iPhone and Google Android platforms. As part of the partnership GWE will research its broad stable of licenses and brands under management and identify which ones will be best suited for TapSlide to develop into mobile applications and games. TapSlide will extend the GWE portfolio of licenses and brands into the new realm of touch screen phones running the latest operating systems from Apple and Google. The partnership will focus on building, marketing and deploying games and applications that utilize the Apple iPhone and Google Android mobile platforms, with a focus on touch screen mobile phones.

"We are very excited to be working with GWE in creating mobile applications for some of their brands," said Mike Stemple, CEO of TapSlide. "Paul and his team at GWE bring a wealth of knowledge and connections to TapSlide and we look forward to some very exciting developments from this partnership."

"Mike Stemple is an industry visionary and has proven that he can create successful products and companies," said Paul Buss, CEO of GWE. "I was so impressed with his last company Skinit.com and the revenue creation it brought for our licenses and brands that we purchased it and made it a part of GWE."

Specific TapSlide/GWE mobile games and applications will be announced in the coming months.

ABOUT GLOBAL WIRELESS ENTERTAINMENT / SKINIT INC.

Global Wireless Entertainment is the parent company to San Diego-based company Skinit, Inc. Skinit is the market leader in mobile consumer electronics personalization with its unique offering of customized, branded (NFL, MLB, NBA, NHL, Collegiate, Disney, Warner Bros, Lucas Arts and many more) and graphic stock designs that total over four million SKUs. Skinit provides leading OEMs, wireless carriers, MVNOs and distributors with turnkey personalization platforms that increase product differentiation, sales velocity, margins and brand impressions. For channel partners, Skinit offers unparalleled capabilities in on-demand manufacturing, fulfillment, supply chain, image portfolio and product line extensions. On the business-to-consumer end, Skinit offers the ultimate in personalization with its Customizer program, enabling end-users to upload, customize, and create their own skins. Skinit's photo quality removable skins made from exclusive 3M Scotchprint graphics are customized to fit consumer electronic devices including mobile handsets, MP3 players, desktop and laptop computers, gaming consoles, routers, and monitors. To learn more about Skinit, visit www.skinit.com.

FEATURED COMPANY

WIND ENERGY AMERICA INCORPORATED (OTCBB: WNEA)

Detailed Quote: www.otcpicks.com/quotes/WNEA.php

Company Profile:
www.otcpicks.com/wind-energy-america/wind-energy-america-2.htm

Wind Energy America Inc. develops and operates wind energy projects in the Great Plains and the Midwest, regions known for their high quality wind energy resources. The Company owns interests in three wind farms: Shaokatan Hills LLC, Lakota Ridge LLC and CHI Energy. At present, WNEA owns a developer's stake and a minimal interest producing negligible cash flow in these wind farms. Over the next two years the developer’s stake will begin producing significant cash flow from these projects. The three wind farms together contain 79 modern wind turbines and have a total rated capacity of 53.5 megawatts (MW). They are collectively generating approximately 160 million kilowatt hours (kWh) of electricity annually. In addition to these properties, the Company owns a 3 percent equity interest in Averill Wind LLC, a 10 MW wind farm being developed near Fargo, N.D., another region favorable for wind power energy.

WNEA News:

November 19 - Wind Energy America Inc. Obtains Financing to Complete Minnesota Wind Farm

Wind Energy America Inc. (OTCBB: WNEA) announced that it has started ordering parts and commencing construction and interconnect operations to complete its wind farm project in Minnesota which contains two of the Gamesa wind turbines acquired in the Boreal Energy asset purchase. When commissioning of these two turbines is completed, WNEA will receive its first material revenues from generating utility-scale electricity from wind power. This Buffalo Ridge wind farm and its revenue production will be 100% owned by WNEA.

Financing for this wind farm project was obtained from a California holding company through a sale/leaseback of our Midwest Energy Center facility in Lincoln County MN. WNEA received net proceeds of approximately $l,400,000 from this sale/leaseback transaction. We also have the option after 2 years to repurchase the facility at a price which represents a small percentage increase over the initial sale/leaseback price.

Robert Knutson, managing director of WNEA and the person responsible for obtaining and closing this significant funding, stated: “Given the current difficulties of raising development capital due to the recent collapse of worldwide equity markets, we are pleased that WNEA has been able to obtain critical funding at this time. These proceeds have enabled us to satisfy substantial overdue bank debt secured by the project, pay for interconnect and other costs owed to the utility which will purchase electricity generated by the project, acquire the necessary transformer equipment and other wind turbine parts and materials, and retain an experienced wind power contractor to complete the project for us.”

FEATURED COMPANY

SUPPORTSAVE SOLUTIONS INCORPORATED (OTCBB: SSVE)

Detailed Quote: http://www.otcpicks.com/quotes/SSVE.php

Company Profile: http://www.otcpicks.com/supportsave-solutions.htm

SupportSave Solutions, Inc. provides offshore business process outsourcing (BPO) services primarily to the United States based clients from its facilities in the Philippines. Its BPO services include customer management, transcription and captioning, processing services, human resources, procurement, logistics support, finance and accounting, engineering, facilities management, information technology, and training. The company also offers credit application processing, mortgage processing, and title searches and data verification services. In addition, it conducts product and fraud detection; manage refunds, warranties, and applications; and offers preparations for serving legal papers. SupportSave Solutions serves small and mid-sized companies in the healthcare, communication, business services, financial services, publishing, and travel and entertainment industries. The company was founded in 2007 and is based in Alamo, California.

SSVE News:

November 24 - SupportSave Opens New Office to Support Customer Demand

SupportSave Expands Sales and Marketing Efforts; Office in Boca Raton, Florida

SupportSave Solutions, Inc. (OTCBB: SSVE), a provider of Business Processing Outsourcing ("BPO") services from the Philippines and the U.S., announced the opening of its new office in Boca Raton, Florida. The addition of the new office will extend SupportSave's market reach and provide additional support and services that are critical to the company's expanding customer base and partner channel.

In the past year, SupportSave has experienced increasing demand for its products and services showing a revenue growth rate of nearly 400%. During the past two years, due to the consistent increase in sales and ongoing development of the company's partner channel, SupportSave strategically grew staff levels to approximately 200 employees and grow its operations center in the Philippines to meet this demand. While continuing to build its infrastructure, the Boca Raton, Florida office will provide additional sales and services resources.

As the company grows, SupportSave's concentration still hinges on providing cost effective services for their customers and partners. Aina Dumlao, chief operating officer at SupportSave, commented, "SupportSave's focus has always been on understanding the client, their environment and the services that they need, whether it is customer service, technical support or back office services." Dumlao continued, "We are committed to ensuring the success of our customers and partners by offering a high quality low cost service model. The Boca Raton office is the next step in advancing that model to meet business demands today, tomorrow and long into the future."

"We are very excited about our year over year growth," stated Chris Johns, chief executive officer at SupportSave. "The continued weakness in the U.S. economy is driving businesses to seek cost effective solutions to keep their businesses relevant and viable while still providing customers the highest levels of support. We have never had such a robust pipeline in our history and this sales office will give us the ability to complete the sales cycle and accelerate our growth," added Johns.

"We chose Boca Raton because of the many talented financial and mortgage professionals displaced by the financial crisis and the ability to attract and retain these sales professionals with our lucrative residual income model. With just modest success, we believe our sales professionals will be earning six figure incomes within a year without cutting into the companies bottom line," continued Johns.

Opening a domestic sales office further demonstrates the counter cyclical nature of SupportSave's business. While other companies are shedding jobs, the Outsourcer is actually adding to its ranks in the U.S.

FEATURED COMPANY

PERF GO GREEN HOLDINGS INCORPORATED (OTCBB: PGOG)

Detailed Quote: www.otcpicks.com/quotes/PGOG.php

Company Profile:
http://www.otcpicks.com/perf-go-green/perf-go-green.htm

Perf Go Green Holdings, Inc. is engaged in the creation and global marketing of 100% eco-friendly, non-toxic, food-contact-compliant, biodegradable plastic products. All Perf Go Green products are made from recycled plastics and completely break down in landfill within two years, leaving no toxic or visible residue, as compared to other plastics that take hundreds of years. Perf Go Green’s corporate name reflects its “Go Green” mission to develop, market and distribute biodegradable plastic products as a practical and viable solution to eliminating plastic waste from the world environment.

PGOG News:

November 24 - Perf Go Green Enters Canadian Market Through Partnership With Diversified Brands

Perf Go Green Holdings, Inc. (OTCBB: PGOG), a marketer and distributor of biodegradable plastics, announced a partnership with Diversified Brands to broker and represent Perf Go Green to retailers throughout Canada.

Founded in 2004, Diversified is a brand development and marketing company with offices in Vancouver, British Columbia and Ajax, Ontario. The firm was recognized in 2007 and 2008 in Profit Magazine's “Hot 50,” which ranks the fastest growing companies in Canada each year.

“This is a great new opportunity for Perf Go Green,” said Chairman and CEO Tony Tracy. “Diversified's management team has a total of 80 years of experience in the Canadian retail market. Their full line of services, combined with their enthusiasm for our mission of protecting the environment, will be a perfect complement to the marketing efforts we already have in place in the U.S.”

Geoff Acheson, CEO of Diversified Brands, added, “We specialize in using our network of relationships with retailers of all sizes to introduce select new brands to the Canadian marketplace and help them grow their presence. Canadians are especially interested in earth-friendly products so we're confident that Perf Go Green will be a big hit with both the nation's retailers and consumers.”

Founded in November 2007, Perf Go Green premiered at the March 2008 International Home and Housewares Show in Chicago, where its products were honored for their design quality and innovation. Since Perf Go Green's products began shipping in June 2008, they have become available online and nationwide in the U.S. at stores with a total of more than 18,000 retail outlets.

Perf Go Green products incorporate recycled plastics that are combined with an oxo-biodegradable proprietary application method to produce the film for its bags. Based on environmental claims statements made by the manufacturer of the oxo-biodegradable applied to our bags, when discarded in soil and exposed to the presence of microorganisms, moisture and oxygen, we believe Perf Go Green products biodegrade within two years, decomposing into simple materials found in nature much faster than regular plastics, which can take hundreds of years to break down. Through this process and the use of recycled plastics, Perf Go Green effectively removes plastic waste from the environment. In addition, Perf Go Green trash bags utilize a unique patented dispensing system that stores the bags on the bottom of trashcans and dispenses them one at a time, similar to a tissue box.

FEATURED COMPANY

MEDIVISOR INCORPORATED (OTC: MVSR)

Detailed Quote: www.otcpicks.com/quotes/MVSR.php

Company Profile: http://www.otcpicks.com/medivisor/medivisor.htm

Medivisor, Inc. provides medical information to healthcare professionals, primarily physicians, through its Web sites, using inter-active, informational, and video and graphic presentations. It also focuses on offering Web site services to various industries seeking direct access to physicians, including providers of continuing medical education courses; sponsors of medical conferences and seminars; and pharmaceutical companies, using an online marketing format known as e-detailing. The company was founded in 2002 and is headquartered in Huntington Station, New York.

MVSR News:

November 19 - Medivisor, Inc. Reaches Marketing Agreement for NICLite®, a Smoking Alternative Drink

Medivisor, Inc. (OTC: MVSR), developer of next-generation focus driven marketing tools, sales strategies, and distribution platforms, announced that it has entered into an agreement with The Curry Group, agent for Nico Worldwide Inc., for the sale and marketing of NICLite®. NICLite® is an alcohol-free Smoking Alternative Drink that is registered with the FDA as a Homeopathic Nicotinum Complex Formula.

Over 2.5 billion people (close to half the world's population) smoke cigarettes. This includes an astounding 48.2 million Americans. Throughout the world, legislation is demanding a ban on smoking. As confirmed in the New England Journal of Medicine, nicotine is a naturally occurring compound. It is found in common foods and vegetables such as potatoes, tomatoes, cauliflower, eggplant, chili peppers, and some types of tea. The World Health Organization has estimated that tobacco smoke contains over 4,000 chemicals, of which nicotine is just one. In addition to tar, there is also carbon monoxide (found in car exhaust fumes), ammonia (found in floor cleaner) and arsenic (found in rat poison). At least 43 of the chemicals in tobacco smoke are known to cause cancers of the lung, throat, mouth, bladder and kidneys. Tobacco smoke also contributes to a number of other cancers.

NICLite® contains a purified organic nicotine molecule in a Complex Homeopathic Formula, which will go into equal suspension in 8 ounces of pharmaceutical grade water. Nico Worldwide Inc. developed NICLite® as a smoking alternative for when people can't smoke, shouldn't smoke or choose not to smoke, and to reduce the craving for tobacco.

"With an increasing number of places and countries banning smoking, NICLite® offers people a real alternative, and the ability to live life smoke free," stated Dino Luzzi, president of Medivisor, Inc. "The potential marketplace for this product is almost limitless."

STOCKS TO WATCH

ONCOGENEX PHARMA INCORPORATED (NASDAQ: OGXI)
"Up 126.22% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/OGXI.php

OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate currently completing five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of specific proteins associated with treatment resistance; OGX-427 and SN2310 are in Phase 1 clinical development; and CSP9222 and OGX-225 are currently in pre-clinical development.

OGXI News:

December 3 - OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study

* First-line trial currently shows median overall survival of 27.5 months for OGX-011 in combination with docetaxel and prednisone and a 16.9 months overall survival for docetaxel and prednisone alone.

* Achievement of survival benefit milestone results in release of all remaining escrowed shares of OGXI.

OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI) announced positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel and prednisone ("the OGX-011 arm") compared to docetaxel and prednisone alone ("the control arm") for first-line treatment of metastatic castrate resistant prostate cancer. The current 10.6 month median overall survival advantage observed in the OGX-011 arm represents an increase over the median survival observed in the control arm. Docetaxel was approved by the FDA based on a survival advantage of 2.4 months over mitoxantrone.

Based on the median overall survival advantage, the Board of Directors of OncoGenex Pharmaceuticals has approved the release of all of the remaining shares held in escrow pursuant to agreements related to Sonus Pharmaceuticals' merger with OncoGenex Technologies described in its Proxy Statement filed with the SEC on July 3, 2008. The escrow agreements provided for the release of 50% of the original number of shares held in escrow following the demonstration of at least a two-month improvement in survival in the OGX-011 arm as compared to the control arm. All milestone shares have now been released from escrow; as of December 3, 2008 there are 5,513,643 shares outstanding.

The trial was conducted and data were analyzed by the National Cancer Institute of Canada, Clinical Trials Group and was supported by a grant from the NCI-Canada with funding from the Canadian Cancer Society. Previous results regarding the primary endpoint analysis (PSA response) were presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) on June 2, 2007.

The study randomized 82 patients with metastatic or locally recurring prostate cancer refractory to hormone therapy. The median survival was 27.5 months for the patients in the OGX-011 arm and 16.9 months for those in the control arm. Results currently indicate that patients in the OGX-011 arm have a death rate approximately 40% lower than patients in the control arm. The current results are based on study data with a median follow-up of approximately 30 months for both arms. Additional survival updates are needed before a mature median survival for the OGX-011 arm can be reported. Based on the current results, OncoGenex has calculated that the final median survival for patients in the OGX-011 arm can not be lower than 22.7 months.

An abstract presenting the mature results is planned to be submitted to the American Society of Clinical Oncology (ASCO) meeting.

LOGICVISION INCORPORATED (NASDAQ: LGVN)
"Up 65.31% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/LGVN.php

LogicVision, Inc. provides technology for the design and manufacture of semiconductor devices. It offers a portfolio of products for the automated development, integration, and deployment of embedded test technology, which consists of technology products, design software products, and manufacturing software products. The company's technology products include the embedded test technology that enables customers to design and manufacture the company's embedded test circuit structures. Its design software products comprise a suite of embedded test design software tools for embedded test implementation on application specific integrated circuits and system-on-a-chip (SoC) designs. The company offers manufacturing software products for access and control of embedded test during chip, and system test program development, debug, manufacturing test, and datalogging. Its technology allows semiconductor designers to insert test structures inside semiconductor integrated circuits, and test the functionality and performance of their devices. The company also provides maintenance, design, and technology development contract services. LogicVision licenses its technologies and software products to companies in semiconductor, semiconductor diagnostics, and systems industries. The company serves application specific integrated circuit or SoC designers in systems and fabless companies, and integrated device manufacturers. It sells its products directly, as well as through distributors or independent sales representatives in the United States and internationally. The company was founded in 1992. It was formerly known as LV Software and changed its name to LogicVision, Inc. in 1996. LogicVision is based in San Jose, California.

LGVN News:

December 3 - Virage Logic proposes to acquire LogicVision for $1.05 per share in cash

Virage Logic Corporation (Nasdaq: VIRL) announced that the company sent a proposal late afternoon on December 2nd to the Board of Directors of LogicVision Incorporated (Nasdaq: LGVN) to acquire LogicVision for $1.05 per share in cash. The proposal provides a premium of 114% to LogicVision’s closing price of $0.49 on December 1, 2008, and values LogicVision at approximately $10.0 million.
The text of the letter that was sent to LogicVision’s Board of Directors follows:

December 2, 2008

Board of Directors
LogicVision, Inc.
25 Metro Drive, Third Floor
San Jose, CA 95110

Dear Sirs:

We are sincerely disappointed in your unwillingness to engage in any substantive discussions regarding our indication of interest transmitted to you on November 10th regarding an all-cash acquisition of LogicVision, Inc. (“LogicVision”) by Virage Logic Corporation (“Virage”). We continue to believe that such a transaction would be to our companies’ mutual benefit, and we are unable to understand your refusal to consider a transaction that would appear to be in your stockholders’ best interests. We note your response that the company is not for sale, which position we believe deserves serious reconsideration. Your refusal to engage in negotiations regarding a possible sale of the company appears to be premised on unrealistic expectations regarding the future prospects of LogicVision. Recent economic events and the resulting downturn in business spending and the semiconductor market cast serious doubts on LogicVision’s long term future as a stand-alone public company.

In response to your apparent unwillingness to engage in negotiations, we are formally making a proposal to acquire all of the outstanding common stock of LogicVision for $1.05 per share in cash, which acquisition would be financed by Virage solely using available cash. This represents a premium of 114% to the closing price for LogicVision’s stock as of December 1, 2008. We believe this to be a very fair offer, and if given the opportunity, your stockholders would also agree. We are offering your stockholders an immediate tangible cash return weighed against an uncertain future for LogicVision as a stand-alone public company and all the associated challenges in light of LogicVision’s current cash position and foreseeable business prospects.

Benefits for LogicVision Stockholders

We note that LogicVision’s previously announced aggressive projections for its current fiscal year appear to be wholly unachievable in light of the downturn in the semiconductor industry and also the rapidly deteriorating macroeconomic environment. In addition, the dramatic decline in LogicVision’s stock price during the previous twelve months has meant a 76% decline to your stockholders in the value of their shares during this same period. We believe your stockholders are aware of, and fully appreciate the risks and challenges confronting LogicVision in the current industry and economic environment and will find the cash value we are offering for their shares to be an attractive alternative to the otherwise uncertain future facing LogicVision.

Business Synergies

Virage supplies a broad line of semiconductor IP solutions to the global semiconductor industry and our mission is to serve as the semiconductor industry’s trusted IP partner. We have a proven reputation as a highly specialized and efficient developer of semiconductor IP, and today more than 350 customers look to Virage to provide much of the core building blocks of their System-on-Chip designs. We believe an acquisition of LogicVision’s business would bring valuable synergies to Virage’s existing business and product lines. We also believe that LogicVision’s existing customers and business partners would benefit from the more complete and diversified product offerings from our combined companies and from a company with Virage’s strong financial position and future.

Process

We have invested considerable time and resources in evaluating the prospective benefits and risks of this transaction and are confident that it could be consummated expeditiously in cooperative partnership with your team. Although we have completed preliminary due diligence based on publicly available information, our proposal is of course subject to the completion of customary due diligence, as well as the negotiation of definitive transaction agreements and the satisfaction of necessary approvals and customary conditions to closing of a transaction to be set forth in such agreements. We together with our advisors would be available to meet with you as soon as arrangements can be made to discuss the terms of this proposal and to commence due diligence and the negotiation of definitive documentation for the transaction. Considering the premium we are offering to LogicVision’s recent trading price and other compelling benefits of this proposal, we are confident that, given the opportunity, LogicVision’s stockholders and customers would be in favor of this offer and the proposed transaction. In light of the foregoing, we ask that you move quickly to engage with us in a meaningful and productive discussion. We look forward to your prompt response.

Very truly yours,

Virage Logic Corporation
\s\J. Daniel McCranie
J. Daniel McCranie
Executive Chairman

ABOUT VIRAGE LOGIC

Virage Logic is a leading provider of semiconductor intellectual property (IP) for the design of complex integrated circuits. The company’s highly differentiated product portfolio includes embedded SRAMs, embedded NVMs, embedded test and repair, logic libraries, memory development software, and DDR memory controller subsystems. As the industry’s trusted semiconductor IP partner, foundries, IDMs and fabless customers rely on Virage Logic to achieve higher performance, lower power, higher density and optimal yield, as well as shorten time-to-market and time-to-volume.

POWER 3 MEDICAL PRODUCTS INCORPORATED (OTCBB: PWRM)
"Up 30.77% in morning trading"

Detailed Quote: www.otcpicks.com/quotes/PWRM.php

Power3 Medical Products Inc. is a leading Bio Medical company engaged in the commercialization of cancer and neurodegenerative disease biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

PWRM News:

December 2 - Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics

Will offer proteomic tests to identify Alzheimer's and Parkinson's disease

Transgenomic, Inc. (OTCBB: TBIO) and Power3 Medical Products, Inc. (OTCBB: PWRM) announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical's Neurodegenerative Biomarkers, which include NuroPro®, a proposed diagnostic for Alzheimer's and Parkinson's disease. Transgenomic plans to offer NuroPro® in its CLIA-certified molecular diagnostics laboratory as well as support the tests with development resources.

Power3's technology assigns a probability score that reflects how closely a patient's sample fits a biostatistical model for a neurological disease (NuroPro®), and indicates if the patient should be recommended for further follow-up by the clinician. These technologies would join Transgenomic's robust portfolio of molecular diagnostics including tests for mitochondrial disorders, oncology and hematology, molecular pathology and inherited diseases.

Craig Tuttle, CEO of Transgenomic, said, "Physicians face a common challenge when treating patients with these devastating diseases -- how to diagnose them earlier and more accurately so their patients can receive treatment sooner and receive greater benefit from treatment. In this respect, the proteomic tests for detection of early disease developed by Power3 are very attractive; particularly when combined with our company's demonstrated strength in robust and sensitive genomics tests for detection of increased disease susceptibility. Moreover, as we are already calling on neurologists with our current lab sales organization, these new assays will add significant depth to our neurological sales portfolio."

Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc., said, "It is critical to have the ability to diagnose Alzheimer's disease more accurately, earlier, and faster than currently available. If physicians can intervene earlier, before the patients suffer debilitation and irreversible damage, the drugs currently used to slow disease progression can be more effective. In addition, the ability to detect Alzheimer's disease processes early and monitor disease progression in the patients' blood will ultimately lead to more effective and personalized treatments."

Helen R. Park, Power3's CEO, said, "This potential agreement will propel the NuroPro® diagnostic test to the next level affording the ability to commercialize a physician sought after test for Alzheimer's and Parkinson's Diseases. It is a win/win for both companies."

A final agreement is subject to due diligence investigation and negotiation of a definitive exclusive license and/or acquisition agreement and approval by the Boards of Directors of both companies.

ABOUT NUROPRO®

NuroPro® is a test designed to diagnose Alzheimer's, Parkinson's, and Lou Gehrig's disease (ALS) in individuals. The test is based on proteomic technology, in which a blood serum sample is drawn from a patient, and the concentration of selected biomarkers residing in a panel of 59 blood serum protein biomarkers of neurodegenerative disease is monitored and the test determines if a patient has a Neurodegenerative disease, such as Alzheimer's, Parkinson's or Lou Gehrig's Disease (ALS).

ABOUT TRANSGENOMIC

Transgenomic is a global biotechnology company that provides unique products and services of automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of Pharmacogenomics and personalized medicine. Specific offerings include WAVE® DHPLC Systems, related consumables and assay kits, Cytogenetics automated systems, and Transgenomic Pharmacogenomics and Reference Laboratory Services. Transgenomic Pharmacogenomics and Laboratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients.

GLU MOBILE INCORPORATED (NASDAQ: GLUU)
"Up 29.17% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/GLUU.php

Glu (Nasdaq: GLUU) is a leading global publisher of mobile games. Its portfolio of top-rated games includes original titles Super K.O. Boxing!, Stranded and Brain Genius, and titles based on major brands from partners including Atari, Activision, Konami, Harrah's, Hasbro, Warner Bros., Microsoft, PlayFirst, PopCap Games, SEGA and Sony. Founded in 2001, Glu is based in San Mateo, Calif. and has offices in London, France, Germany, Spain, Italy, Sweden, Poland, Russia, China, Brazil, Chile, Canada and Mexico.

GLUU News:

December 3 - Glu to Develop and Publish Mobile Game Based on Highly-Anticipated Film Watchmen

Glu Mobile Inc. (Nasdaq: GLUU), a leading global publisher of mobile games, today announced that it will be publishing a mobile game based on the forthcoming Warner Bros. Pictures super hero film Watchmen. The game will launch worldwide in conjunction with the film’s U.S. premiere in March 2009. Watchmen, based on the most celebrated graphic novel of all-time published by DC Comics, is a thrilling mystery-adventure set in an alternate 1985 America where heroes roam as members of society.

“We are excited to continue our relationship with Warner Bros. to create the mobile game based on this highly anticipated film,” said Jill Braff, senior vice president of global publishing, Glu Mobile. “Like the film, the mobile game will engage long-time fans of the novel, as well as those who are getting to know Watchmen for the first time.”

Today’s announcement marks the fifth title Glu will develop and publish through its licensing agreement with Warner Bros. Digital Distribution. Other titles developed with WBDD include Speed Racer, The Dark Knight, Superman/Batman: Heroes United and Bugs Bunny: Rabbit Rescue.

Watchmen is known for its unconventional take on the lives of super heroes, depicting them as real people, confronting the trials and tribulations of everyday human life. The film is being directed by Zack Snyder who was behind the success of the box office hit 300. The cast includes such stars as Billy Crudup as Dr. Manhattan, Jeffrey Dean Morgan as The Comedian and Matthew Goode in the role of Ozymandias. Other Watchmen are played by Malin Ackerman, Carla Gugino, Jackie Earle Haley and Patrick Wilson.

Watchmen: The Mobile Game will be supported by a suite of personalization content which will be available to consumers in early 2009. For more information, visit www.glu.com.

ABOUT DC COMICS

DC Comics, a Warner Bros. Entertainment Company, is the largest English-language publisher of comics in the world and home to such iconic characters as Superman, Batman, Wonder Woman and the Sandman. These DC Super Heroes and others have starred in comic books, movies, television series (both animated and live-action) and cyberspace, thrilling audiences of all ages for generations.

RAM HOLDINGS LIMITED (NASDAQ: RAMR)
"Up 16.67% in morning trading"

Detailed Quote: www.otcpicks.com/quotes/RAMR.php

RAM Holdings Ltd. is a Bermuda-based holding company. Its operating subsidiary RAM Reinsurance Company Ltd. provides financial guaranty reinsurance for U.S. and international public finance and structured finance transactions. More information can be found at www.ramre.com.

RAMR News:

December 1 - RAM Holdings Announces Commutation of $10.6 Billion Par MBIA Portfolio Including $6.8 Billion Par of Structured Finance Transactions

RAM Holdings Ltd. (Nasdaq: RAMR) announced that its operating subsidiary, RAM Reinsurance Company Ltd. ("RAM Re") has entered into a Commutation Agreement, effective November 30, 2008, to commute its entire $10.6 billion portfolio of business assumed from MBIA Insurance Corporation and affiliates effective upon receipt by MBIA of a commutation payment of $156.5 million, which includes return of $51.5 million of unearned premium reserves (calculated on a U.S. statutory basis) and $61.3 million of estimated loss reserves and impairments (a non-GAAP measure) as of September 30, 2008.

The commuted portfolio of $10.6 billion par outstanding (as of September 30, 2008) consists of:

* $6.8 billion par of structured finance transactions including
* $439.3 million of collateralized debt obligations of asset-backed securities (ABS CDOs) (all structured as credit derivatives)
* $2.4 billion of collateralized debt obligations of commercial mortgage-backed securities (CMBS CDOs)
* $453.0 million of 2005 - 2008 vintage U.S. residential mortgage-backed securities (RMBS)
* $3.8 billion of public finance transactions including
* $1.2 billion of international public finance transactions

As of RAM's September 30, 2008 financial information, the commuted portfolio represented approximately:

* 98% of RAM's total unrealized losses on ABS CDO credit derivatives contracts
* 100% of total par outstanding of ABS CDOs for which RAM has established credit impairments
* 37% of total loss reserves for RMBS transactions
* 45% of total par outstanding of RMBS for which RAM has established case reserves
* 99% of total par outstanding of CMBS CDO transactions

As at September 30, 2008, estimated Bermuda statutory capital and surplus of RAM Re was $193.6 million, and the estimated minimum required statutory capital and surplus was $24.9 million. RAM Re’s estimated Bermuda statutory capital and surplus as of September 30, 2008 would have been $147.9 million if the MBIA commutation had been effected at September 30, 2008, exceeding the estimated minimum requirement which would have been $14.2 million. The fair market value of the portion of RAM Re’s portfolio not held in trust for the benefit of its ceding companies would have been $117.1 million if the MBIA commutation had been effected at September 30, 2008. In addition, RAM Re still has access to $50 million from its Blue Water Trust committed preferred securities facility, should RAM require additional liquidity. As such, RAM continues to believe that it will be able to meet expected claims payments and operating expenses for the foreseeable future, barring further unexpected deterioration in the insured portfolio.

Commenting on the commutation, Vernon M. Endo, RAM's Chief Executive Officer, said, "This commutation represents another milestone in RAM's efforts to restructure its insured portfolio. As a result of the MBIA commutation, we have reshaped our insurance portfolio by reducing our overall exposure to ABS CDOs and 2005 – 2008 vintage US RMBS by more than 64% and 27%, respectively. After the commutation, U.S. public finance exposure will increase from 51.3% to 60.1% of our portfolio."

RAM will update its insured portfolio disclosure on its website at www.ramre.bm under Investor Information/Exposure Info and Updates to show the effect of the MBIA commutation on RAM’s insured portfolio as of September 30, 2008. In addition, RAM will provide additional information on the effect of the commutation on its insurance portfolio and financial results when it releases its earnings for the fourth quarter.

ASCENT SOLAR TECHNOLOGIES INCORPORATED (NASDAQ: ASTI)
"Up 20.50% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/ASTI.php

Ascent Solar Technologies, Inc. is a developer of thin-film photovoltaic modules with substrate materials that can be more flexible and affordable than most traditional solar panels. Ascent Solar modules can be directly integrated into standard building materials, space applications, consumer electronics for portable power or configured as stand alone modules for large scale terrestrial deployment. Ascent Solar is located in Littleton, Colorado.

ASTI News:

December 2 - Ascent Solar Achieves Significant Efficiency Milestone

Ascent Solar Technologies, Inc. (Nasdaq: ASTI), a developer of state of the art flexible thin-film solar modules, today announced that it has achieved greater than 9.5% efficiency for its flexible Copper, Indium, Gallium, Selenide (CIGS) monolithically integrated modules.

The U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) has independently verified that the modules measured as high as 9.64% in conversion efficiency. The modules tested at NREL were produced from the company’s 1.5MW pilot production line.

“We have been working to achieve these efficiencies during our internal optimization process, and we view this achievement as a tremendous breakthrough. The test modules measure six inches wide by one foot long and serves as our building block for portable power and building integrated photovoltaic (BIPV) products,” said Dr. Prem Nath, Sr. Vice President of Manufacturing for Ascent Solar. “Our goal continues to be the commercialization of flexible thin-film CIGS modules using a plastic substrate, which we hope will uniquely position Ascent Solar to provide light weight flexible photovoltaic material at low cost.”

Lawrence Kazmerksi, Executive Director at NREL, said, “This is significant. Many doubted that a thin-film CIGS solar cell-on-plastic technology could be possible. Ascent Solar not only achieved this, but they now have confirmed efficiencies at NREL on fully integrated, monolithic prototype modules near 10%. This appears to be a substantial leap toward realizing high-performance, inexpensive thin-film solar photovoltaics.”

ABOUT NATIONAL RENEWABLE ENERGY LABORATORY

The National Renewable Energy Laboratory (NREL) is the nation's primary laboratory for renewable energy and energy efficiency research and development.